H-Index & Metrics Top Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Biology and Biochemistry H-index 217 Citations 227,797 509 World Ranking 8 National Ranking 5

Research.com Recognitions

Awards & Achievements

2005 - Member of the National Academy of Sciences

2002 - Member of the National Academy of Medicine (NAM)

1999 - Fellow of the American Academy of Arts and Sciences

Member of the Association of American Physicians


What is he best known for?

The fields of study he is best known for:

  • Gene
  • Enzyme
  • Cancer

His primary areas of investigation include Cell biology, Apoptosis, Biochemistry, Programmed cell death and Molecular biology. His Cell biology research is multidisciplinary, incorporating elements of Autophagy, Bcl-2 family and Bcl-2-associated X protein. Craig B. Thompson focuses mostly in the field of Apoptosis, narrowing it down to matters related to Cell culture and, in some cases, Cancer research and Gene product.

In his research, BCL-2 Gene Family is intimately related to Transfection, which falls under the overarching field of Programmed cell death. Craig B. Thompson interconnects Gene expression, CD28, T cell, Cytochrome c and CD3 in the investigation of issues within Molecular biology. His CD28 study which covers IL-2 receptor that intersects with Interleukin 21.

His most cited work include:

  • Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation (8625 citations)
  • Apoptosis in the pathogenesis and treatment of disease (6030 citations)
  • Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death (3385 citations)

What are the main themes of his work throughout his whole career to date?

Craig B. Thompson mainly focuses on Cell biology, Molecular biology, Apoptosis, T cell and Programmed cell death. The Cell biology study combines topics in areas such as Receptor, Biochemistry and Cell growth. As a part of the same scientific study, Craig B. Thompson usually deals with the Molecular biology, concentrating on Gene expression and frequently concerns with Regulation of gene expression.

His Apoptosis research is multidisciplinary, incorporating perspectives in Cell culture, Transfection and Cancer research. Bcl-2 family is the focus of his Programmed cell death research. His studies in Signal transduction integrate themes in fields like Kinase and Intracellular.

He most often published in these fields:

  • Cell biology (53.19%)
  • Molecular biology (26.51%)
  • Apoptosis (20.13%)

What were the highlights of his more recent work (between 2010-2021)?

  • Cell biology (53.19%)
  • Biochemistry (14.40%)
  • Cancer research (13.58%)

In recent papers he was focusing on the following fields of study:

Craig B. Thompson spends much of his time researching Cell biology, Biochemistry, Cancer research, Cancer cell and Glutamine. Particularly relevant to Signal transduction is his body of work in Cell biology. His studies deal with areas such as Leukemia, Epigenetics, Mutant and Stem cell as well as Cancer research.

His Mutant research is multidisciplinary, relying on both Biomarker and Molecular biology. Craig B. Thompson interconnects Tumor microenvironment, Glycolysis and Pinocytosis in the investigation of issues within Cancer cell. His research in Glutamine intersects with topics in Cell, Asparagine, Cell culture and Citric acid cycle.

Between 2010 and 2021, his most popular works were:

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3242 citations)
  • The Emerging Hallmarks of Cancer Metabolism (1872 citations)
  • Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate (1862 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Enzyme
  • Cancer

Craig B. Thompson mostly deals with Cell biology, Biochemistry, Glutamine, Metabolism and Cancer cell. His work carried out in the field of Cell biology brings together such families of science as Autophagy, Cancer and Cell growth. The various areas that Craig B. Thompson examines in his Glutamine study include Extracellular, Cell culture, Citrate synthase and In vivo.

His Metabolism course of study focuses on PI3K/AKT/mTOR pathway and Carnitine O-palmitoyltransferase, Warburg effect and AMP-activated protein kinase. Morphogenesis, Reprogramming and Embryonic stem cell is closely connected to Tumor microenvironment in his research, which is encompassed under the umbrella topic of Cancer cell. The concepts of his Signal transduction study are interwoven with issues in Mitochondrion and Effector.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Top Publications

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

Matthew G. Vander Heiden;Lewis C. Cantley;Craig B. Thompson.
Science (2009)

11684 Citations

Apoptosis in the pathogenesis and treatment of disease

Craig B. Thompson.
Science (1995)

9446 Citations

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky;Fabio C. Abdalla;Hagai Abeliovich;Robert T. Abraham.
Autophagy (2012)

7068 Citations

bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death

Lawrence H. Boise;Maribel González-García;Christina E. Postema;Liyun Ding.
Cell (1993)

4658 Citations

Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death

Michael C. Wei;Wei-Xing Zong;Emily H.-Y. Cheng;Tullia Lindsten.
Science (2001)

4552 Citations


Ralph J. DeBerardinis;Julian J. Lum;Georgia Hatzivassiliou;Craig B. Thompson.
Cell Metabolism (2008)

3620 Citations

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

Tilman Oltersdorf;Steven W. Elmore;Alexander R. Shoemaker;Robert C. Armstrong.
Nature (2005)

3605 Citations

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

Lenny Dang;David W. White;Stefan Gross;Bryson D. Bennett.
Nature (2009)

3442 Citations

Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4

Paul Waterhouse;Josef M. Penninger;Emma Timms;Andrew Wakeham.
Science (1995)

3148 Citations

Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell death

Elizabeth Yang;Jiping Zha;Jennifer Jockel;Lawrence H Boise.
Cell (1995)

2667 Citations

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us

Top Scientists Citing Craig B. Thompson

Guido Kroemer

Guido Kroemer

Sorbonne University

Publications: 354

John C. Reed

John C. Reed

Sanford Burnham Prebys Medical Discovery Institute

Publications: 279

Andreas Strasser

Andreas Strasser

Walter and Eliza Hall Institute of Medical Research

Publications: 237

Matthew G. Vander Heiden

Matthew G. Vander Heiden


Publications: 221

David C. S. Huang

David C. S. Huang

Walter and Eliza Hall Institute of Medical Research

Publications: 184

Douglas R. Green

Douglas R. Green

St. Jude Children's Research Hospital

Publications: 167

Lewis C. Cantley

Lewis C. Cantley

Cornell University

Publications: 140

Lorenzo Galluzzi

Lorenzo Galluzzi

Cornell University

Publications: 139

Carl H. June

Carl H. June

University of Pennsylvania

Publications: 138

Ralph J. DeBerardinis

Ralph J. DeBerardinis

The University of Texas Southwestern Medical Center

Publications: 138

Arlene H. Sharpe

Arlene H. Sharpe

Harvard University

Publications: 136

Jason W. Locasale

Jason W. Locasale

Duke University

Publications: 120

Jeffrey C. Rathmell

Jeffrey C. Rathmell

Vanderbilt University Medical Center

Publications: 116

Eileen White

Eileen White

Rutgers, The State University of New Jersey

Publications: 113

Benoit Viollet

Benoit Viollet

Université Paris Cité

Publications: 112

Something went wrong. Please try again later.